Natural killer T cell ligand α-galactosylceramide inhibited lymph node metastasis of highly metastatic melanoma cells

Japanese Journal of Cancer Research

Volumn 90, Issue 8, 1999, Pages 801-804

  Nakui, Minoru ^a   Iwakabe, Kenji ^a   Ohta, Akio ^a   Sekimoto, Masashi ^a   Sato, Marimo ^a   Makuuchi, Hiroyasu ^a   Kawano, Tetsu ^b   Taniguchi, Masaru ^b   Nishimura, Takashi ^a  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Immunotherapy; Melanoma; Metastasis; NKT; galaclosylceramide

Indexed keywords

GALACTOSYLCERAMIDE; LIGAND;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER IMMUNOTHERAPY; CONTROLLED STUDY; INTRAVENOUS DRUG ADMINISTRATION; LUNG; LYMPH NODE METASTASIS; MELANOMA; METASTASIS; MOUSE; NATURAL KILLER CELL; NONHUMAN; OVARY; PLEURA; PRIORITY JOURNAL;

EID: 0032862029     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1999.tb00818.x     Document Type: Article

References (12)

1. Fearon, D. T. and Locksley, R. M. The instructive role of innate immunity in the acquired immune response. Science, 272, 50-54 (1996).
2. Trinchieri, G. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol., 13, 251-276 (1995).
3. Nishimura, T., Watanabe, K., Yahata, T., Lee, U., Ando, K., Kimura, M., Saiki, I., Uede, T. and Habu, S. Application of interleukin 12 to antitumor cytokine and gene therapy. Cancer Chemother. Pharmacol., 38, S27-S34 (1996).
4. Cui, J., Shin, T., Kawano, T., Sato, H., Kondo, E., Toura, I., Kaneko, Y., Koseki, H., Kanno, M. and Taniguchi, M. Requirement for Vα14 NKT cells in IL-12-mediated rejection of tumors. Science, 278, 1623-1626 (1997).
5. Nakagawa, R., Motoki, K., Ueno, H., Iijima, R., Nakamura, H., Kobayashi, E., Shimosaka, A. and Koezuka, Y. Treatment of hepatic metastasis of the colon26 adenocarcinoma with an α-galactosylceramide, KRN7000. Cancer Res., 58, 1202-1207 (1998).
6. + T-cell antigen receptor a chain expanded in unprimed mice. Proc. Natl. Acad. Sci. USA, 87, 5248-5252 (1990).
7. Kitamura, H., Iwakabe, K., Yahata, T., Nishimura, S., Ohta, A., Ohmi, Y., Sato, M., Takeda, K., Okumura, K., Van Kaer, L., Kawano, T., Taniguchi, M. and Nishimura, T. The natural killer T (NKT) cell ligand α-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells. J. Exp. Med., 189, 1121-1128 (1999).
8. Kawano, T., Cui, J., Koezuka, Y., Toura, I., Kaneko, Y., Motoki, K., Ueno, H., Nakagawa, R., Sato, H., Kondo, E., Koseki, H. and Taniguchi, M. CD1d-restricted and TCR-mediated activation of Vα14 NKT cells by glycosylceramides. Science, 278, 1626-1629 (1997).
9. + NKT lymphocytes. J. Immunol., 161, 3271-3281 (1998).
10. Kawano, T., Cui, J., Koezuka, Y., Toura, I., Kaneko, Y., Sato, H., Kondo, E., Harada, M., Koseki, H., Nakayama, T., Tanaka, Y. and Taniguchi, M. Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Vα14 NKT cells. Proc. Natl. Acad. Sci. USA, 95, 5690-5693 (1998).
11. Kodama, T., Takeda, K., Shimozato, O., Hayakawa, Y., Atsuta, M., Kobayashi, K., Ito, M., Yagita, T. and Okumura, K. Perforin-dependent NK cell cytotoxicity is sufficient for anti-metastatic effect of IL-12. Eur. J. Immunol., 29, 1390-1396 (1999).
12. Nishimura, T., Burakoff, S. J. and Hermann, S. H. Protein kinase C required for cytotoxic T lymphocyte triggering. J. Immunol., 130, 2888-2891 (1987).